CITIGROUP INC - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 109 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$61,570
-84.6%
24,336
-59.5%
0.00%
Q2 2023$400,013
-82.0%
60,062
-49.5%
0.00%
-100.0%
Q1 2023$2,220,074
+16597.3%
118,975
+19120.5%
0.00%
Q4 2022$13,296
+47.7%
619
-20.0%
0.00%
Q3 2022$9,000
-62.5%
774
-58.0%
0.00%
Q2 2022$24,000
-92.5%
1,841
-88.0%
0.00%
Q1 2022$321,000
-79.6%
15,365
-80.2%
0.00%
-100.0%
Q4 2021$1,577,000
+32.0%
77,552
+97.0%
0.00%0.0%
Q3 2021$1,195,000
-60.6%
39,362
-62.3%
0.00%
-50.0%
Q2 2021$3,034,000
-19.3%
104,413
+19.8%
0.00%0.0%
Q1 2021$3,761,000
+2727.8%
87,142
+2928.9%
0.00%
Q4 2020$133,000
+104.6%
2,877
+92.4%
0.00%
Q3 2020$65,000
-92.4%
1,495
-90.8%
0.00%
-100.0%
Q2 2020$857,000
+1763.0%
16,171
+679.7%
0.00%
Q1 2020$46,000
+130.0%
2,074
+49.1%
0.00%
Q4 2019$20,000
+900.0%
1,391
+366.8%
0.00%
Q3 2019$2,000
-88.9%
298
-82.3%
0.00%
Q2 2019$18,000
+12.5%
1,688
+5.1%
0.00%
Q1 2019$16,0001,6060.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Logos Global Management LP 430,000$19,866,0001.70%
APIS CAPITAL ADVISORS, LLC 20,000$924,0000.89%
Avidity Partners Management LP 547,000$25,271,0000.82%
Knoll Capital Management, LLC 20,000$924,0000.63%
Artemis Investment Management LLP 1,013,448$46,839,0000.49%
AlphaCentric Advisors LLC 25,000$1,155,0000.48%
First Light Asset Management, LLC 94,202$4,352,0000.32%
Ikarian Capital, LLC 150,000$6,930,0000.31%
Longitude (Cayman) Ltd. 8,000$370,0000.18%
AllSquare Wealth Management LLC 5,490$254,0000.17%
View complete list of BIOXCEL THERAPEUTICS INC shareholders